Vanguard Discloses Position in Mural Oncology

The Vanguard Group, Inc. has filed Form 8.3 regarding its position in Mural Oncology plc, as per the Irish Takeover Panel rules. As of August 12, 2025, Vanguard holds 771,939 ordinary shares in Mural Oncology, representing 4.47% of relevant securities. This filing follows the requirement for disclosure by entities with interests exceeding 1% in involved securities.

No deals involving options, derivatives, or new securities have been declared. Vanguard performed a sale of 432 ordinary shares at $1.66 each. No additional agreements or dealings impacting securities were reported. The disclosure highlights Vanguard's transparency and compliance with Irish regulations during potential corporate changes involving Mural Oncology.